Credit Suisse Raises Salix Pharmaceuticals Price Target
December 18, 2014 at 14:42 PM EST
Credit Suisse raised its price target on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) from $111 to $121 and maintained a Neutral ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.